Advanced Immune Therapeutic Strategies (AIT Strategies) is a biomedical firm specializing in translational immunology, clinical development, regulatory strategy and product development. We are innovators in the field of "indirect immunization", a terminology introduced by our founder Dr. Christopher Nicodemus. We work with academic collaborators, biotechnology companies and contract research organizations to facilitate development of novel therapies in cancer and other therapeutic areas.
“If you prevent something from happening but hadn’t known it was going to happen, you would be unaware of your accomplishment”---That circumstance may still be true in the case of Covid-19’s severe respiratory progression. I advocate for replicating small prospective randomized clinical trials as an effective way to screen for actionable interventions in the face of pandemics. Visit the Covid-19 tab of this web site to follow my perspectives on the pandemic and its amazing evolution .
C Nicodemus MD FACP (expert in experimental clinical immunology)
You have reached the home page of Advanced Immune Therapeutic Strategies -- AIT Strategies
Immune complexes processed by dendritic cells